Apolonia Novillo
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variants.
Journal: The pharmacogenomics journal
Published: February 19, 2026
Chd4 and ThPOK cooperate to preserve structural and electrophysiological integrity of the adult heart through Sprr1a repression.
Journal: The FEBS journal
Published: January 06, 2026
In silico Analysis of CHD4 Mutations Reveals Domain-Specific Impacts on Cardiovascular Disorders Among Patients With Rare Diseases.
Journal: Human mutation
Published: February 03, 2025
Worldwide distribution of genetic factors related to severity of COVID-19 infection.
Journal: Annals of human biology
Published: July 16, 2024
HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment.
Journal: Cancers
Published: December 16, 2022
miR-7, miR-10a and miR-143 Expression May Predict Response to Bevacizumab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer.
Journal: Pharmacogenomics and personalized medicine
Published: April 02, 2021
Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer.
Journal: International journal of molecular sciences
Published: January 07, 2021
Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer.
Journal: Frontiers in oncology
Published: November 24, 2020
Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports.
Journal: World journal of gastroenterology
Published: January 07, 2020
Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast Cancer.
Journal: Journal of oncology
Published: October 28, 2019
Last Updated: 09/26/2026